The DOI matches its Crossref record; 40 of the 42 references it cites were found in a registry or an index.
Selective inhibition of BET bromodomains
Open accessAbstract
Epigenetic proteins are intently pursued targets in ligand discovery. So far, successful efforts have been limited to chromatin modifying enzymes, or so-called epigenetic 'writers' and 'erasers'. Potent inhibitors of histone binding modules have not yet been described. Here we report a cell-permeable small molecule (JQ1) that binds competitively to acetyl-lysine recognition motifs, or bromodomains. High potency and specificity towards a subset of human bromodomains is explained by co-crystal structures with bromodomain and extra-terminal (BET) family member BRD4, revealing excellent shape complementarity with the acetyl-lysine binding cavity. Recurrent translocation of BRD4 is observed in a genetically-defined, incurable subtype of human squamous carcinoma. Competitive binding by JQ1 displaces the BRD4 fusion oncoprotein from chromatin, prompting squamous differentiation and specific antiproliferative effects in BRD4-dependent cell lines and patient-derived xenograft models. These data establish proof-of-concept for targeting protein-protein interactions of epigenetic 'readers', and provide a versatile chemical scaffold for the development of chemical probes more broadly throughout the bromodomain family.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Previous studies have reported that SALL4 is an IMiD-dependent CRL4CRBN substrate (Donovan et al, 2018; Filippakopoulos et al, 2010).”
From Targeting transcription factors through an IMiD independent zinc finger domain (2025) · cites this paper as Filippakopoulos et al, 2010
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Buchdunger, E., Zimmermann, J., Mett, H., Meyer, T., Müller, M., Regenass, U., & Lydon, N. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.7.2558 · Cited by 273
RetractedDruker, B. J., Talpaz, M., Resta, D. J., Peng, B., Buchdunger, E., Ford, J., Lydon, N., Kantarjian, H. M., Capdeville, R., Ohno-Jones, S., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200104053441401 · Cited by 5,237
Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr–Abl positive cells
Druker, B. J., Tamura, S., Buchdunger, E., Ohno-Jones, S., Segal, G. M., Fanning, S., Zimmermann, J., & Lydon, N. (1996) · Nature Medicine · doi:10.1038/nm0596-561 · Cited by 3,652
Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia
Huang, M., Ye, Y., Chen, S. R., Chai, J., Lu, J., Zhoa, L., Gu, L.-J., & Wang, Z.-Y. (1988) · Blood · doi:10.1182/blood.v72.2.567.567 · Cited by 2,445
Niesen, F., Berglund, H., & Vedadi, M. (2007) · Nature Protocols · doi:10.1038/nprot.2007.321 · Cited by 2,420
Structural Mechanism for STI-571 Inhibition of Abelson Tyrosine Kinase
Schindler, T. H., Bornmann, W. G., Pellicena, P., Miller, W. T., Clarkson, B., & Kuriyan, J. (2000) · Science · doi:10.1126/science.289.5486.1938 · Cited by 1,785
c-Myc Regulates Transcriptional Pause Release
Rahl, P. B., Lin, C. Y., Seila, A. C., Flynn, R. A., McCuine, S., Burge, C. B., Sharp, P. A., & Young, R. A. (2010) · Cell · doi:10.1016/j.cell.2010.03.030 · Cited by 1,279
Recruitment of P-TEFb for Stimulation of Transcriptional Elongation by the Bromodomain Protein Brd4
Yang, Z., Yik, J. H. N., Chen, R., He, N., Jang, M. K., Ozato, K., & Zhou, Q. (2005) · Molecular Cell · doi:10.1016/j.molcel.2005.06.029 · Cited by 1,141
Buchdunger, E., Zimmermann, J., Mett, H., Meyer, T., Müller, M., Druker, B. J., & Lydon, N. (1996) · PubMed · Cited by 1,057
Bromodomain: an acetyl‐lysine binding domain
Zeng, L., & Zhou, M. (2002) · FEBS Letters · doi:10.1016/s0014-5793(01)03309-9 · Cited by 751
Control of RNA Polymerase II Elongation Potential by a Novel Carboxyl-terminal Domain Kinase
Marshall, N. F., Peng, J., Xie, Z., & Price, D. H. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.43.27176 · Cited by 662
Brd4 Coactivates Transcriptional Activation of NF-κB via Specific Binding to Acetylated RelA
Huang, B., Yang, X., Zhou, M., Ozato, K., & Chen, L. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.01365-08 · Cited by 604
Marshall, N. F., & Price, D. H. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.21.12335 · Cited by 564
Owen, D. J., Ornaghi, P., Yang, J., Lowe, N., Evans, P. R., Ballario, P., Neuhaus, D., Filetici, P., & TRAVERS, A. A. (2000) · The EMBO Journal · doi:10.1093/emboj/19.22.6141 · Cited by 543
Identification of multiple cyclin subunits of human P-TEFb.Preprint
Peng, J.-M., Zhu, Y., Milton, J. T., & Price, D. (1998) · Genes & Development · doi:10.1101/gad.12.5.755 · Cited by 531
BRD4-NUT fusion oncogene: a novel mechanism in aggressive carcinoma.
French, C. A., Miyoshi, I., Kubonishi, I., Grier, H. E., Pérez‐Atayde, A. R., & Fletcher, J. A. (2003) · PubMed · Cited by 503
Self-citationFrench, C. A., Ramirez, C. L., Kolmakova, J., Hickman, T. T., Cameron, M. J., Thyne, M. E., Kutok, J. L., Toretsky, J. A., Tadavarthy, A. K., Kees, U. R., et al. (2007) · Oncogene · doi:10.1038/sj.onc.1210852 · Cited by 441
Self-citationDiagnosis of NUT Midline Carcinoma Using a NUT-specific Monoclonal Antibody
Haack, H., Johnson, L. A., Fry, C. J., Crosby, K., Polakiewicz, R. D., Stelow, E. B., Hong, S., Schwartz, B. E., Cameron, M. J., Rubin, M. A., et al. (2009) · The American Journal of Surgical Pathology · doi:10.1097/pas.0b013e318198d666 · Cited by 437
Self-citationSignaling Network Model of Chromatin
Schreiber, S. L., & Bernstein, B. (2002) · Cell · doi:10.1016/s0092-8674(02)01196-0 · Cited by 399
Frye, S. V. (2010) · Nature Chemical Biology · doi:10.1038/nchembio.296 · Cited by 375
In Vivo Eradication of Human BCR/ABL-Positive Leukemia Cells With an ABL Kinase Inhibitor
le Coutre, P., Mologni, L., Cleris, L., Marchesi, E., Buchdunger, E., Giardini, R., Formelli, F., & Gambacorti-Passerini, C. B. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.2.163 · Cited by 372
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases
Fedorov, O., Marsden, B. D., Pogačić, V., Rellos, P., Müller, S., Bullock, A. N., Schwaller, J., Sundström, M., & Knapp, S. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0708800104 · Cited by 362
Self-citationYang, Z., He, N., & Zhou, Q. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.01020-07 · Cited by 349
Brd4 Marks Select Genes on Mitotic Chromatin and Directs Postmitotic Transcription
Dey, A., Nishiyama, A., Karpova, T., McNally, J. G., & Ozato, K. (2009) · Molecular Biology of the Cell · doi:10.1091/mbc.e09-05-0380 · Cited by 319
A Bromodomain Protein, MCAP, Associates with Mitotic Chromosomes and Affects G2-to-M Transition
Dey, A., Ellenberg, J., Farina, A., Coleman, A., Maruyama, T., Sciortino, S., Lippincott‐Schwartz, J., & Ozato, K. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.17.6537-6549.2000 · Cited by 304
Multisite protein modification and intramolecular signaling
Yang, X. (2004) · Oncogene · doi:10.1038/sj.onc.1208173 · Cited by 272
Chemical probes for histone-modifying enzymes
Cole, P. A. (2008) · Nature Chemical Biology · doi:10.1038/nchembio.111 · Cited by 253
BRD4 Bromodomain Gene Rearrangement in Aggressive Carcinoma with Translocation t(15;19)
French, C. A., Miyoshi, I., Aster, J. C., Kubonishi, I., Kroll, T. G., Cin, P. D., Vargas, S. O., Pérez‐Atayde, A. R., & Fletcher, J. A. (2001) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63049-0 · Cited by 204
Self-citationBullock, A. N., Debreczeni, J. E., Fedorov, O., Nelson, A. S., Marsden, B. D., & Knapp, S. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm0504858 · Cited by 157
Self-citationPhelps, M. A., Lin, T. S., Johnson, A. J., Hurh, E., Rozewski, D. M., Farley, K. L., Wu, D., Blum, K. A., Fischer, B., Mitchell, S. M., et al. (2008) · Blood · doi:10.1182/blood-2008-07-168583 · Cited by 156
You, J., Srinivasan, V., Denis, G. V., Harrington, W. J., Ballestas, M. E., Kaye, K. M., & Howley, P. M. (2006) · Journal of Virology · doi:10.1128/jvi.00502-06 · Cited by 147
Structures of the Dual Bromodomains of the P-TEFb-activating Protein Brd4 at Atomic Resolution
Vollmuth, F., Blankenfeldt, W., & Geyer, M. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.033712 · Cited by 137
Activation of chromatin by acetylation of histone side chains.
Marushige, K. (1976) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.73.11.3937 · Cited by 137
Abbate, E. A., Voitenleitner, C., & Botchan, M. R. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.11.002 · Cited by 120
A crowdsourcing evaluation of the NIH chemical probes
Oprea, T. I., Bologa, C., Boyer, S. K., Curpan, R. F., Glen, R. C., Hopkins, A. L., Lipinski, C. A., Marshall, G. R., Martin, Y. C., Halip, L., et al. (2009) · Nature Chemical Biology · doi:10.1038/nchembio0709-441 · Cited by 111
Regulation of Aurora B Expression by the Bromodomain Protein Brd4
You, J., Li, Q., Wu, C., Kim, J., Ottinger, M., & Howley, P. M. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.00299-09 · Cited by 72
Toretsky, J. A., Jenson, J., Sun, C. J., Eskenazi, A. E., Campbell, A., Hunger, S. P., Caires, A., Frantz, C. N., Hill, J. L., & Stamberg, J. (2003) · American Journal of Clinical Oncology · doi:10.1097/01.coc.0000020960.98562.84 · Cited by 67
Quinn, A. M., Bedford, M. T., Espejo, A. B., Spannhoff, A., Austin, C. P., Oppermann, U. C. T., & Simeonov, A. M. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkp899 · Cited by 56
Binding reactions: epigenetic switches, signal transduction and cancer
Ptashne, M. (2009) · Current Biology · doi:10.1016/j.cub.2009.02.015 · Cited by 44
Alprazolam: Review of pharmacological, pharmacokinetic, and clinical data
VonVoigtlander, P. F., & Straw, R. N. (1985) · Drug Development Research · doi:10.1002/ddr.430060102 · Cited by 31
Flagged first, then by citations
2 of the 42 references couldn’t be matched to a known paper.
Research works printed but not linked: 1
- Sueoka, H., Komatsu, H., Kobayashi, H. & Ehara, S. Thienotriazolodiazepine Compounds and Medicinal Uses Thereof 1–50 (Yoshitomi Pharmaceutical Industries, Ltd, 1998)
Cited by
Sorted by citations
Cancer epigenetics: from mechanism to therapy
Dawson, M. A., & Kouzarides, T. (2012) · Cell · doi:10.1016/j.cell.2012.06.013 · Cited by 3,203
Comprehensive molecular characterization of urothelial bladder carcinoma
Perou, C. M. (2014) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/za09-dk57 · Cited by 2,922
Selective Inhibition of Tumor Oncogenes by Disruption of Super-Enhancers
Lovén, J., Hoke, H. A., Lin, C. Y., Lau, A., Orlando, D. A., Vakoc, C. R., Bradner, J. E., Lee, T. I., & Young, R. A. (2013) · Cell · doi:10.1016/j.cell.2013.03.036 · Cited by 2,961
Self-citationBET Bromodomain Inhibition as a Therapeutic Strategy to Target c-Myc
Delmore, J. E., Issa, G. C., Lemieux, M. E., Rahl, P. B., Shi, J., Jacobs, H. M., Kastritis, E., Gilpatrick, T., Paranal, R. M., Qi, J., et al. (2011) · Cell · doi:10.1016/j.cell.2011.08.017 · Cited by 2,888
Self-citationA decade of exploring the cancer epigenome—biological and translational implications
Baylin, S. B., & Jones, P. A. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3130 · Cited by 2,871
Metadata
- Authors
- Filippakopoulos, P., Qi, J., Picaud, S., Shen, Y., Smith, W. B., Fedorov, O., Morse, E. M., Keates, T., Hickman, T. T., Felletar, I., Philpott, M., Munro, S., McKeown, M. R., Wang, Y., Christie, A. L., West, N., Cameron, M. J., Schwartz, B., Heightman, T. D., La Thangue, N., French, C. A., Wiest, O., Kung, A. L., Knapp, S., & Bradner, J. E.
- Affiliations
- University of Oxford (GB)
- Harvard University (US)
- University of Notre Dame (US)
- Brigham and Women's Hospital (US)
- Boston Children's Hospital (US)
- Corresponding author
- Knapp, Stefan
- Bradner, James E.
- ORCID
- Venue
- Nature
- Published
- 2010-09-24
- Volume
- 468
- Issue
- 7327
- Pages
- 1067-1073
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC3010259
- OpenAlex
- W2041535798
- Cited by
- 4,262
- References
- 42
- Citations by year
- 2026: 217 · 2025: 307 · 2024: 304 · 2023: 307 · 2022: 309 · 2021: 323 · 2020: 340 · 2019: 323 · 2018: 303 · 2017: 306 · 2016: 334 · 2015: 279 · 2014: 246 · 2013: 177 · 2012: 117
- FWCI
- 48.89
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Oxford University Research Archive (ORA) (University of Oxford) (submittedVersion)
- Funders
- Wellcome Trust
- Cancer Research UK (13058)
- U.S. Public Health Service (T32-075762)
- Canadian Institutes of Health Research
- National Cancer Institute (K08CA128972)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Degradation and Inhibitors
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Chromatin Remodeling and Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
- Keywords
- BET inhibitors, JQ1, BRD4, epigenetic reader protein, protein-protein interaction inhibition, squamous cell carcinoma, histone acetylation, co-crystal structure, chemical probes, transcriptional regulation
- MeSH terms
- Bromodomain Containing Proteins, Amino Acid Sequence, Animals, Azirines, Binding Sites, Carcinoma, Squamous Cell, Cell Differentiation, Chromatin, Dihydropyridines, Female, Humans, Mice, Nude, Models, Molecular, Molecular Sequence Data, Nuclear Proteins, Protein Binding, Recombinant Proteins, Skin Neoplasms, Stereoisomerism, Transcription Factors, Sequence Alignment, Protein Structure, Tertiary, Cell Cycle Proteins, Cell Line, Tumor, Cell Proliferation, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
